| Literature DB >> 31959762 |
Sherry B Hildreth1,2, Evan E Foley1, Gloria K Muday3, Richard F Helm2, Brenda S J Winkel4.
Abstract
While the effects of phytohormones on plant gene expression have been well characterized, comparatively little is known about how hormones influence metabolite profiles. This study examined the effects of elevated auxin and ethylene on the metabolome of Arabidopsis roots using a high-resolution 24 h time course, conducted in parallel to time-matched transcriptomic analyses. Mass spectrometry using orthogonal UPLC separation strategies (reversed phase and HILIC) in both positive and negative ionization modes was used to maximize identification of metabolites with altered levels. The findings show that the root metabolome responds rapidly to hormone stimulus and that compounds belonging to the same class of metabolites exhibit similar changes. The responses were dominated by changes in phenylpropanoid, glucosinolate, and fatty acid metabolism, although the nature and timing of the response was unique for each hormone. These alterations in the metabolome were not directly predicted by the corresponding transcriptome data, suggesting that post-transcriptional events such as changes in enzyme activity and/or transport processes drove the observed changes in the metabolome. These findings underscore the need to better understand the biochemical mechanisms underlying the temporal reconfiguration of plant metabolism, especially in relation to the hormone-metabolome interface and its subsequent physiological and morphological effects.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31959762 PMCID: PMC6971091 DOI: 10.1038/s41598-019-57161-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Summary of features discovered by UPLC-MS analysis of Arabidopsis roots.
| MS Method | Total identified by XCMS | Following deconvolution by RamClustR | Different following IAA treatment | Different following ACC treatment | Shared between IAA and ACC |
|---|---|---|---|---|---|
| Reversed Phase Negative | 883 | 260 | 36 | 39 | 6 |
| Reversed Phase Positive | 438 | 154 | 19 | 24 | 7 |
| HILIC Negative | 1612 | 76 | 11 | 10 | 4 |
| HILIC Positive | 580 | 97 | 13 | 8 | 2 |
Features identified as being different following either treatment are those exhibiting at least a two-fold difference relative to untreated controls in all three biological replicates based on paired univariate analysis.
Figure 1Scores plots derived from sPLS-DA of the reversed phase negative mode metabolomic profiles of ACC- and IAA-treated roots over 24 h. Symbols and colors for each of the eight time points are identified at upper right.
Figure 2Identification of major patterns associated with time, hormone treatment, and their interactions. The patterns of abundance over time are shown for the two features identified by ASCA, oxIAA hexose (A) and coumaroyl aspartate (B), and one uncovered by targeted analysis, the flavonoid glycoside rutin (C). Note that the x axis is not drawn on a linear scale; this is to allow for better visualization of the data points for early sampling times.
Putatively-identified root metabolites exhibiting robust changes in response to auxin.
| Metabolite | EMRT | Method | Average log two-fold change after transfer to hormone-containing medium | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.5 h | 1 h | 2 h | 4 h | 8 h | 12 h | 24 h | |||
| IAA hexose* | 306.41_336.1079 | RP-Neg | − | 1.9 | − | −1.7 | 1.1 | 2.1 | −1.8 |
| oxIAA hexose | 273.02_352.1028 | RP-Neg | 1.7 | 1.9 | |||||
| 6-hydroxyindole-3-carboxylate dihexose | 172.03_500.1401 | RP-Neg | − | 2.6 | −2.9 | −1.8 | 1.6 | 2.0 | −1.2 |
| 6-hydroxyindole-3-carboxylate hexose | 190.42_338.0873 | RP-Neg | − | 1.4 | −3.2 | −1.7 | 1.2 | 1.9 | −1.6 |
| 4-methoxy-3-indolylmethyl glucosinolate | 296.17_477.0638 | RP-Neg | −1.7 | 1.1 | − | −1.8 | 1.7 | 4.1 | −1.2 |
| quercetin hexose hexose* | 258.76_625.1406 | RP-Neg | 1.4 | 1.3 | 2.0 | −1.1 | −1.1 | ||
| quercetin hexose hexose deoxyhexose | 292.71_771.1982 | RP-Neg | 1.5 | 1.7 | 1.7 | 1.6 | −1.1 | 1.2 | |
| quercetin hexose deoxyhexose deoxyhexose | 306.01_755.2032 | RP-Neg | 1.6 | 2.2 | 1.1 | 2.1 | 1.2 | 1.2 | |
| quercetin hexose deoxyhexose (rutin) | 307.99_609.1459 | RP-Neg | 1.6 | 1.8 | 1.3 | 1.5 | −1.2 | 1.1 | |
| quercetin deoxyhexose pentose | 314.09_579.135_ | RP-Neg | 1.6 | 1.5 | 1.8 | 1.2 | 1.2 | ||
| quercetin hexose | 352.44_463.0873 | RP-Neg | 1.2 | 1.9 | 2.3 | −1.5 | 1.3 | ||
| isorhamnetin hexose deoxyhexose | 335.2_623.1614 | RP-Neg | 1.4 | 2.0 | 1.6 | 1.7 | −1.1 | 1.3 | |
| isorhamnetin hexose | 386.17_477.1031 | RP-Neg | 1.0 | 1.7 | 3.6 | −1.3 | 1.2 | ||
| kaempferol hexose deoxyhexose | 329.4_593.151 | RP-Neg | 1.3 | 2.0 | 1.4 | 1.4 | −1.0 | 1.3 | |
| kaempferol hexose deoxyhexose deoxyhexose* | 327.01_739.2083 | RP-Neg | 1.0 | 1.1 | 2.0 | 1.1 | 1.7 | ||
| kaempferol deoxyhexose deoxyhexose* | 354.4_577.1557 | RP-Neg | 1.3 | 2.3 | 1.2 | 3.0 | −1.1 | 1.6 | |
| kaempferol hexose | 379.71_447.0924 | RP-Neg | 1.3 | 4.6 | 2.1 | 3.6 | −1.0 | 1.4 | |
| coumaric acid hexose (isomer a) | 265.14_325.092 | RP-Neg | −1.0 | 2.9 | −1.1 | 3.9 | −1.4 | 1.3 | |
| coumaric acid hexose (isomer b) | 278.71_325.092 | RP-Neg | −1.2 | 1.4 | −1.2 | 4.4 | −1.2 | −1.4 | |
| caffeic acid hexose | 232.68_341.0869 | RP-Neg | 1.0 | 2.2 | −1.4 | 4.1 | −1.4 | 1.1 | |
| coumaroyl aspartate | 271.05_278.0659 | RP-Neg | 1.1 | 2.4 | 1.5 | ||||
| phosphatidylcholine 34:2 | 170.7_796.523 | HILIC-Pos | 3.4 | −1.1 | 1.3 | −1.7 | −1.8 | − | |
| phosphatidylcholine 34:3 | 171.23_756.554 | HILIC-Pos | 4.3 | −1.1 | 1.3 | −1.8 | −2.2 | − | |
| phosphatidylcholine 36:5 | 171.16_780.554 | HILIC-Pos | 4.8 | 3.3 | −1.1 | 1.5 | −1.7 | −1.8 | − |
| phosphatidylcholine 36:4 | 170.85_782.568 | HILIC-Pos | 4.5 | 3.9 | −1.2 | 1.4 | −1.8 | −1.8 | − |
| trihydroxyhexadecanoic acid hexose* | 481.27_465.2694 | RP-Neg | 1.9 | −1.4 | 1.4 | −1.4 | 1.7 | 1.2 | |
Included are all metabolites with features that differed ≥ 2 fold relative to the time-matched control in all three biological replicates at one or more sampling times; values that meet these criteria are shown in bold and are underlined. Values are the average fold change for the three replicates, with positive numbers indicating elevated levels and negative numbers indicating reduced levels relative to untreated controls. Putative identifications are based on fragmentation patterns obtained by MS/MS and MSE, with further details available in Table S1. Asterisks identify the five metabolites common to the auxin and ethylene datasets. RP = reversed phase; HILIC = hydrophilic interaction chromatography.
Putatively-identified root metabolites exhibiting robust changes in response to ethylene.
| Metabolite | EMRT | Method | Average log two-fold change after transfer to hormone-containing medium | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.5 h | 1 h | 2 h | 4 h | 8 h | 12 h | 24 h | |||
| 4-methylsulfinylbutyl glucosinolate | 73.32_436.0403 | RP-Neg | − | −1.6 | −1.2 | −2.1 | 1.5 | 4.7 | −3.8 |
| 7-methylsulfinylheptyl glucosinolate | 374.59_478.0873/238.06_478.0875 | RP-Neg/HILIC-Neg | − | −1.5 | −1.1 | −1.3 | 2.2 | 2.2 | |
| 8-methylsulfinyloctyl glucosinolate | 432.65_492.103/230.65_492.1032 | RP-Neg/HILIC-Neg | − | −1.7 | −1.2 | −1.4 | 2.6 | 3.2 | |
| 4-methylthiobutyl glucosinolate | 233.56_420.0453 | RP-Neg | −2.3 | −2.6 | −1.5 | −2.3 | 1.5 | 4.0 | |
| 5-methylthiopentyl glucosinolate and hydroxy-8-methylsulfinyl octyl glucosinolate (isomer a) | 284.19_434.061 | RP-Neg | −1.9 | −2.4 | −1.3 | −1.6 | 1.2 | 2.1 | |
| hydroxy-8-methylsulfinyl-octyl glucosinolate (isomer b) | 244.53_508.098 | RP-Neg | −3.6 | −1.5 | −1.2 | −1.2 | 2.6 | 2.0 | |
| 7-methylthioheptyl glucosinolate | 399.01_462.0926 | RP-Neg | −1.6 | −1.7 | −1.0 | −1.5 | 1.3 | 2.4 | |
| 8-methylthiooctyl glucosinolate | 454.6_476.1082 | RP-Neg | −1.6 | −1.6 | −1.1 | −1.4 | 1.0 | 1.9 | |
| 4-benzoyloxy | 379.81_494.0789 | RP-Neg | −1.4 | −2.8 | −1.3 | −1.7 | 1.5 | 3.1 | |
| 340.76_477.0637 | RP-Neg | −2.2 | −2.7 | −1.4 | −1.1 | 1.5 | 2.8 | ||
| 165.11_558.281 | HILIC-Pos | 1.5 | −1.4 | 1.3 | 1.4 | −1.2 | −1.1 | ||
| quercetin hexose hexose* | 258.76_625.1406 | RP-Neg | 1.7 | 1.7 | 1.2 | 2.1 | 1.8 | −1.0 | |
| quercetin-containing unknown | 432.71_835.2083 | RP-Neg | 1.9 | 2.6 | 1.3 | 2.9 | 2.3 | −1.1 | |
| kaempferol deoxyhexose deoxyhexose* | 354.4_577.1557 | RP-Neg | 2.0 | 1.4 | 1.3 | −1.1 | 1.4 | 1.4 | |
| kaempferol hexose deoxyhexose deoxyhexose* | 327.01_739.2083 | RP-Neg | 1.4 | 1.2 | 2.4 | 1.1 | 2.8 | 1.6 | |
| G(8-O4)S(8-5)FA hexose | 474.1_759.25 | RP-Neg | 1.2 | 1.4 | −1.2 | 1.7 | 2.0 | −1.4 | |
| hexose G(8-O-4)FA malate + 238 | 495.4_789.2605 | RP-Neg | 1.1 | 1.2 | −1.1 | 1.1 | 2.2 | −1.3 | |
| hexose G(8-O-4) FA malate + 238 | 470.52_789.2605 | RP-Neg | 1.4 | 1.4 | −1.1 | 1.3 | 2.3 | −1.4 | |
| IAA hexose* | 306.41_336.1079 | RP-Neg | 3.2 | −1.3 | −1.6 | 2.4 | −1.3 | −1.3 | − |
| trihydroxyhexadecanoic acid hexose* | 481.27_465.2694 | RP-Neg | 2.9 | 2.4 | 3.6 | − | − | − | |
Included are all metabolites with features that differed ≥ 2 fold relative to the time-matched control in all three biological replicates at one or more sampling times; values that meet these criteria are shown in bold and are underlined. Values are the average fold change for the three replicates, with positive numbers indicating elevated levels and negative numbers indicating reduced levels relative to the untreated controls. Putative identifications are based on fragmentation patterns obtained by MS/MS and MSE, with further details available in Table S1. Asterisks identify the five metabolites common to the auxin and ethylene datasets. RP = reversed phase; HILIC = hydrophilic interaction chromatography. Standard abbreviations are used for oligolignols, with G, S, and FA = guaiacyl units, syringyl units, and ferulic acid, respectively.
Transcripts associated with auxin-responsive metabolic processes.
| ID | Gene Number | ProbeSet No. | Average SLR change after transfer to hormone-containing medium | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 h | 0.5 h | 1 h | 2 h | 4 h | 8 h | 12 h | 24 h | |||
| DAO1* | AT1G14130 | 262653_at | −0.27 | 0.23 | −0.15 | 0.32 | 0.03 | − | −0.47 | 0.08 |
| DAO2* | AT1G14120 | 262608_at | 0.02 | −0.26 | − | −0.54 | − | − | − | −0.55 |
| GH3.1 | AT2G14960 | 266611_at | −0.02 | |||||||
| GH3.3* | AT2G23170 | 245076_at | −0.56 | |||||||
| GH3.5 | AT4G27260 | 253908_at | −0.10 | |||||||
| GH3.6* | AT5G54510 | 248163_at | 0.00 | |||||||
| CYP79B2† | AT4G39950 | 252827_at | −0.23 | 0.24 | −0.56 | − | −0.54 | −0.15 | −0.15 | 0.04 |
| CYP79B3† | AT2G22330 | 264052_at | −0.08 | −0.17 | −0.25 | −1.30 | − | −0.49 | −0.24 | −0.37 |
| NIT1, NIT2 | AT3G44310 AT3G44300 | 252678_s_at | −0.05 | −0.24 | −0.22 | 0.29 | −0.16 | − | − | −0.53 |
| UGT74E2* | AT1G05680 | 263231_at | 0.06 | −0.20 | − | −0.57 | − | − | − | −1.68 |
| PIN1 | AT1G73590 | 259845_at | −0.02 | 0.48 | 0.17 | 0.34 | ||||
| PIN3 | AT1G70940 | 262263_at | −0.14 | |||||||
| PIN7 | AT1G23080 | 264900_at | 0.00 | |||||||
| ASP4 | AT1G62800 | 262646_at | −0.17 | −0.10 | −0.06 | −0.56 | − | −0.57 | −0.31 | −0.02 |
| ACO1* | AT2G19590 | 265948_at | 0.03 | −0.20 | 0.33 | 0.68 | ||||
| ACO3* | AT1G12010 | 264346_at | −0.02 | −0.08 | 0.04 | 0.47 | ||||
| ACO4 | AT1G05010 | 265194_at | −0.08 | 0.14 | 0.00 | −0.23 | − | −0.52 | −0.38 | 0.47 |
| ACS5 | AT5G65800 | 247159_at | 0.09 | −0.22 | −0.20 | −0.58 | − | −0.59 | − | −0.40 |
| ACS6 | AT4G11280 | 254926_at | −0.05 | 0.61 | 0.38 | 0.00 | − | 0.45 | ||
| ACS7 | AT4G26200 | 253999_at | −0.17 | 0.51 | −0.33 | −0.41 | −0.26 | − | − | −0.34 |
| ACS8 | AT4G37770 | 253066_at | 0.07 | 0.65 | 0.20 | 0.27 | ||||
| ACS9 | AT3G49700 | 252279_at | 0.12 | |||||||
| ACS11* | AT4G08040 | 255177_at | 0.05 | 0.26 | ||||||
| BCAT4* | AT3G19710 | 257021_at | −0.32 | 0.09 | −0.35 | 0.34 | 0.24 | 0.21 | ||
| CYP79F1, CYP79F2 | AT1G16410 AT1G16400 | 262717_s_at | −0.20 | 0.39 | −0.12 | 0.12 | 0.19 | −0.03 | 0.39 | |
| CYP79B2† | AT4G39950 | 252827_at | −0.23 | 0.24 | −0.56 | − | −0.54 | −0.15 | −0.15 | 0.04 |
| CYP79B3† | AT2G22330 | 264052_at | −0.08 | −0.17 | −0.25 | −1.30 | − | −0.49 | −0.24 | −0.37 |
| CYP81F2* | AT5G57220 | 247949_at | −0.48 | −0.26 | −0.64 | − | 0.45 | −0.40 | −0.66 | − |
| CYP83A1* | AT4G13770 | 254687_at | −0.15 | 0.01 | −0.02 | 0.31 | 0.34 | 0.03 | 0.54 | |
| UGT74B1 | AT1G24100 | 264873_at | −0.27 | 0.29 | −0.36 | −0.73 | − | −0.50 | −0.19 | 0.23 |
| PAL1 | AT2G37040 | 263845_at | 0.01 | −0.19 | −0.45 | −0.59 | −0.63 | − | −0.57 | −0.21 |
| PAL2 | AT3G53260 | 251984_at | 0.01 | −0.12 | −0.36 | −0.24 | −0.33 | − | −0.63 | −0.47 |
| PAL4* | AT3G10340 | 259149_at | 0.06 | −0.17 | −0.39 | −0.84 | − | 0.30 | 0.02 | −0.14 |
| 4CL1 | AT1G51680 | 256186_at | 0.13 | −0.05 | −0.43 | −0.55 | − | −0.35 | −0.40 | −0.04 |
| 4CL3* | AT1G65060 | 261907_at | 0.18 | −0.34 | −0.27 | −0.46 | −0.61 | − | −0.30 | −0.58 |
| CCR2 | AT1G80820 | 261899_at | 0.01 | −0.22 | − | −0.38 | −0.17 | −0.33 | 0.09 | −0.21 |
| F5H/ CYP84A1* | AT4G36220 | 261899_at | −0.17 | 0.23 | −0.23 | −0.39 | −0.10 | 0.45 | ||
| CYP84A4 (F5H activity) | AT5G04330 | 245710_at | −0.07 | −0.25 | −0.15 | − | − | − | − | −0.35 |
| CCOAMT* | AT1G67980 | 260015_at | −0.50 | 0.17 | − | −0.10 | 0.65 | 0.54 | 0.54 | − |
| CCOAOMT7* | AT4G26220 | 253985_at | 0.27 | −0.29 | −0.07 | 0.13 | −0.17 | − | − | − |
| ALDH2C4* | AT3G24503 | 258140_at | −0.15 | 0.07 | 0.12 | 0.72 | 0.33 | 0.30 | −0.29 | |
| CAD-like | AT1G30760 | 264527_at | 0.00 | 0.00 | 0.31 | |||||
| CAD6 | AT4G37970 | 253017_at | 0.19 | −0.46 | −0.89 | −0.18 | 0.77 | 0.84 | ||
| CAD8 | AT4G39330 | 252943_at | 0.03 | 0.12 | −0.31 | 0.20 | 0.15 | 0.33 | ||
| CHS | AT5G13930 | 250207_at | 0.34 | −0.53 | −0.36 | −0.33 | −0.45 | − | 0.51 | −0.76 |
| CHI* | AT2G43570 | 260568_at | −0.32 | 0.26 | − | 0.38 | 0.53 | −0.05 | 0.15 | −0.03 |
| F3H* | AT3G51240 | 252123_at | 0.31 | −0.53 | −0.55 | − | − | − | −0.02 | −0.60 |
| F3’H* | AT5G07990 | 250558_at | 0.31 | −0.54 | −0.50 | −0.58 | −0.34 | − | −0.07 | −0.54 |
| UGT71C3* | AT1G07260 | 256053_at | −0.01 | −0.36 | −0.43 | −0.30 | 0.11 | 0.43 | 0.65 | |
| FAH1 | AT2G34770 | 267318_at | 0.23 | −0.16 | −0.55 | − | − | − | −0.37 | −0.48 |
| ACC2* | AT1G36180 | 256459_at | 0.13 | −0.29 | −0.24 | 0.04 | −0.29 | −0.61 | − | −0.17 |
| BCCP2 | AT5G15530 | 246565_at | 0.15 | −0.17 | 0.08 | −0.28 | −0.45 | −0.42 | − | −0.61 |
| NBRFSP | AT4G13180 | 254759_at | −0.07 | 0.53 | 0.63 | −0.26 | −0.56 | −0.05 | ||
| PLDALPHA1 | AT3G15730 | 258226_at | 0.03 | −0.01 | 0.24 | 0.13 | 0.26 | 0.27 | 0.32 | |
| PLDGAMMA1* | AT4G11850 | 254847_at | −0.12 | 0.09 | 0.10 | 0.18 | 0.39 | 0.33 | 0.35 | |
| PLDDELTA | AT4G35790 | 253120_at | 0.06 | −0.15 | −0.16 | −0.60 | − | −0.59 | −0.44 | −0.06 |
| NPC3 | AT3G03520 | 259169_at | −0.11 | 0.04 | −0.31 | − | − | −0.08 | −0.03 | 0.15 |
| NPC4, NPC5* | AT3G03540 AT3G03530 | 259221_s_at | 0.27 | −0.13 | −0.28 | −0.16 | 0.07 | 0.25 | −0.10 | |
| LCAT4 | AT4G19860 | 254547_at | 0.04 | −0.30 | −0.11 | −0.28 | − | −0.17 | −0.12 | 0.10 |
| PLA2-ALPHA | AT2G06925 | 266500_at | 0.12 | 0.16 | 0.00 | −0.15 | 0.15 | 0.66 | ||
| PLA-IBETA2 | AT4G16820 | 245447_at | −0.03 | 0.64 | 0.06 | 0.43 | 0.59 | 0.34 | ||
| PLP1, PLAIVA* | AT4G37070 | 246252_s_at | −0.04 | −0.37 | −0.36 | − | − | −0.69 | −0.71 | −0.68 |
Shown are genes having average log two-fold values relative to time-matched controls of ≥ 0.5 or ≤ −0.5 (~1.4 or −1.4-fold differences) in all three biological replicates at one or more sampling times (data from 11,12), with values meeting these criteria shown in bold and are underlined. Positive numbers indicate elevated levels and negative numbers indicate reduced levels relative to the untreated controls. The full list of genes examined for each class with values for each biological replicate are provided in Datafile S5. † denotes genes that participate in indole glucosinolate biosynthesis and thus are listed under two categories. Asterisks identify genes that meet the criteria for change in response to both auxin and ethylene. Enzyme abbreviations are as follows: 4CL (4-coumaroyl coenzyme A ligase), ACC (acetyl-CoA carboxylase), ACO (ACC oxidase), ACS (ACC synthase), ALDH (aldehyde dehydrogenase), ASP (aspartate aminotransferase), BCAT (branched-chain-amino-acid aminotransferase), CAD (cinnamyl-alcohol dehydrogenase), CAT (lecithin-cholesterol acyltransferase-like), CCOAMT (caffeoyl-CoA O-methyltransferase), CCoAOMT7 (caffeoyl-coenzyme A O-methyltransferase), CHI (chalcone isomerase), CHS (chalcone synthase), DAO (DIOXYGENASE FOR AUXIN OXIDATION), F3H (flavanone 3-hydroxylase), F3’H (flavonoid 3’-hydroxylase), FLS (flavonol synthase), GH (GRETCHEN HAGEN), NIT (nitrilase), NPC (non-specific phospholipase C), PAL (phenylalanine ammonia-lyase), PLA (phospholipase A), PLD (phospholipase D), PLP (patatin-like protein), UGT (uridine diphosphate-glycosyltransferase).
Transcripts associated with ethylene-responsive metabolic processes.
| ID | Gene Number | ProbeSet No. | Average SLR change after transfer to hormone-containing medium | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 h | 0.5 h | 1 h | 2 h | 4 h | 8 h | 12 h | 24 h | |||
| DAO1* | AT1G14130 | 262653_at | −0.34 | 0.17 | −0.26 | −0.03 | −0.50 | − | − | −0.17 |
| DAO2* | AT1G14120 | 262608_at | −0.09 | −0.21 | −0.27 | −0.23 | − | − | − | −0.84 |
| GH3.3* | AT2G23170 | 245076_at | −0.36 | 0.98 | −0.14 | −0.17 | 0.16 | 0.48 | 0.30 | |
| GH3.6* | AT5G54510 | 248163_at | 0.26 | −0.39 | −0.50 | −0.46 | −0.50 | −0.35 | −0.42 | |
| CYP71A13 | AT2G30770 | 267567_at | 0.26 | 0.50 | − | −0.42 | −0.13 | −0.43 | − | 0.17 |
| UGT74E2* | AT1G05680 | 263231_at | 0.16 | 0.59 | −0.98 | − | − | − | − | − |
| ACO1* | AT2G19590 | 265948_at | 0.16 | 0.38 | ||||||
| ACO2 | AT1G62380 | 260637_at | −0.03 | 0.35 | 0.41 | |||||
| ACO3* | AT1G12010 | 264346_at | 0.04 | 0.24 | ||||||
| ACO5 | AT1G77330 | 246390_at | −0.13 | −0.32 | ||||||
| ACS11* | AT4G08040 | 255177_at | −0.41 | −0.60 | −0.47 | −0.15 | 0.18 | 0.18 | 0.14 | |
| BCAT4* | AT3G19710 | 257021_at | 0.49 | −0.19 | −0.38 | −0.79 | −0.03 | 0.48 | 0.101 | |
| CYP81F2* | AT5G57220 | 247949_at | 0.13 | 0.97 | 0.00 | −0.67 | 0.93 | 1.81 | ||
| CYP83A1* | AT4G13770 | 254687_at | −0.32 | 0.16 | −0.50 | 0.36 | 0.60 | −0.07 | ||
| CYP83B1 | AT4G31500 | 253534_at | −0.52 | 0.43 | −0.29 | 0.19 | 0.20 | 0.17 | 0.22 | |
| SOT18 | AT1G74090 | 260385_at | 0.13 | 0.04 | 0.08 | −0.43 | 0.35 | 0.31 | −0.01 | |
| PAL4* | AT3G10340 | 259149_at | −0.07 | 0.28 | −0.43 | −0.37 | − | −0.56 | −0.78 | −0.60 |
| 4CL3* | AT1G65060 | 261907_at | 0.44 | −0.34 | −0.20 | −0.09 | −0.38 | −0.35 | −0.27 | − |
| F5H, CYP84A1* | AT4G36220 | 261899_at | −0.14 | −0.50 | 0.01 | −0.39 | −0.38 | −0.67 | −0.35 | − |
| CCOAMT* | AT1G67980 | 260015_at | −0.17 | 1.40 | −0.40 | 0.48 | ||||
| CCOAOMT7* | AT4G26220 | 253985_at | 0.20 | −0.44 | 0.47 | 0.63 | 0.48 | 0.25 | ||
| ALDH2C4* | AT3G24503 | 258140_at | −0.02 | 0.51 | 0.38 | 0.48 | 0.37 | 0.52 | 0.29 | |
| OMT1 | AT5G54160 | 248200_at | 0.08 | 0.06 | 0.27 | |||||
| CHI* | AT2G43570 | 260568_at | 0.12 | 0.78 | − | −0.28 | 0.37 | 0.09 | 0.12 | |
| F3H* | AT3G51240 | 252123_at | 0.44 | −0.60 | −0.34 | 0.00 | −0.48 | −0.26 | −0.03 | − |
| F3’H* | AT5G07990 | 250558_at | 0.64 | −0.72 | −0.22 | −0.26 | −0.58 | − | −0.46 | − |
| FLS1 | AT5G08640 | 250533_at | −0.48 | −0.23 | 0.07 | −0.08 | −0.03 | 0.18 | −0.67 | |
| UGT71C3* | AT1G07260 | 256053_at | 0.02 | 0.16 | 0.14 | 0.18 | 0.38 | 0.88 | ||
| ACC2* | AT1G36180 | 256459_at | 0.41 | −0.13 | −0.20 | −0.19 | −0.52 | −0.57 | − | −0.62 |
| PLDEPSILON | AT1G55180 | 259657_at | 0.09 | 0.16 | −0.25 | 0.12 | −0.10 | 0.04 | −0.07 | − |
| PLDGAMMA1* | AT4G11850 | 254847_at | 0.24 | 0.87 | 0.12 | 0.12 | 0.64 | 0.72 | 0.73 | |
| PLDDELTA | AT4G35790 | 253120_at | 0.01 | −0.02 | −0.07 | −0.34 | − | −0.51 | −0.60 | −0.45 |
| NPC4, NPC5* | AT3G03540 AT3G03530 | 259221_s_at | 0.31 | −0.19 | −0.33 | −0.39 | −0.47 | − | − | − |
| PLP1, AtPLAIVA* | AT4G37070 | 246252_s_at | 0.07 | 0.45 | 0.10 | −0.64 | − | −0.43 | −0.75 | −0.43 |
Shown are genes having average log two-fold values relative to time-matched controls of ≥ 0.5 or ≤ −0.5 (~1.4 or −1.4-fold differences) in all three biological replicates at one or more sampling times (data from 11,12), with values meeting these criteria shown in bold and are underlined. Positive values indicate elevated levels and negative values indicate reduced levels relative to untreated controls. The full list of genes examined for each class with values for each biological replicate are provided in Datafile S5. Asterisks identify genes that meet the criteria for change in response to both auxin and ethylene. Enzyme abbreviations are as defined for Table 4.